Vallicelli Carlo, Santandrea Giorgia, Sartelli Massimo, Coccolini Federico, Ansaloni Luca, Agnoletti Vanni, Bravi Francesca, Catena Fausto
General, Emergency and Trauma Surgery Department, Bufalini Hospital, 47521 Cesena, Italy.
Department of Surgery, Macerata Hospital, 62100 Macerata, Italy.
Antibiotics (Basel). 2022 Oct 23;11(11):1460. doi: 10.3390/antibiotics11111460.
. Sepsis is an overwhelming reaction to infection with significant morbidity, requiring urgent interventions in order to improve outcomes. The 2016 Sepsis-3 guidelines modified the previous definitions of sepsis and septic shock, and proposed some specific diagnostic and therapeutic measures to define the use of fluid resuscitation and antibiotics. However, some open issues still exist. . A literature research was performed on PubMed and Cochrane using the terms "sepsis" AND "intra-abdominal infections" AND ("antibiotic therapy" OR "antibiotic treatment"). The inclusion criteria were management of intra-abdominal infection (IAI) and effects of antibiotic stewardships programs (ASP) on the outcome of the patients. Sepsis-3 definitions represent an added value in the understanding of sepsis mechanisms and in the management of the disease. However, some questions are still open, such as the need for an early identification of sepsis. Sepsis management in the context of IAI is particularly challenging and a prompt diagnosis is essential in order to perform a quick treatment (source control and antibiotic treatment). Antibiotic empirical therapy should be based on the kind of infection (community or hospital acquired), local resistances, and patient's characteristic and , and should be adjusted or de-escalated as soon as microbiological information is available. Antibiotic Stewardship Programs (ASP) have demonstrated to improve antimicrobial utilization with reduction of infections, emergence of multi-drug resistant bacteria, and costs. Surgeons should not be alone in the management of IAI but ideally inserted in a sepsis team together with anaesthesiologists, medical physicians, pharmacists, and infectious diseases specialists, meeting periodically to reassess the response to the treatment. The cornerstones of sepsis management are accurate diagnosis, early resuscitation, effective source control, and timely initiation of appropriate antimicrobial therapy. Current evidence shows that optimizing antibiotic use across surgical specialities is imperative to improve outcomes. Ideally every hospital and every emergency surgery department should aim to provide a sepsis team in order to manage IAI.
脓毒症是对感染的一种严重反应,具有较高的发病率,需要紧急干预以改善预后。2016年脓毒症-3指南修改了先前脓毒症和脓毒性休克的定义,并提出了一些具体的诊断和治疗措施来界定液体复苏和抗生素的使用。然而,一些未解决的问题仍然存在。在PubMed和Cochrane上使用“脓毒症”、“腹腔内感染”以及(“抗生素治疗”或“抗生素疗法”)等术语进行了文献研究。纳入标准为腹腔内感染(IAI)的管理以及抗生素管理计划(ASP)对患者预后的影响。脓毒症-3定义在理解脓毒症机制和疾病管理方面具有附加价值。然而,一些问题仍然悬而未决,比如早期识别脓毒症的必要性。IAI背景下的脓毒症管理尤其具有挑战性,快速诊断对于进行快速治疗(源头控制和抗生素治疗)至关重要。抗生素经验性治疗应基于感染类型(社区或医院获得性)、局部耐药性以及患者特征,并且一旦获得微生物学信息就应进行调整或降阶梯治疗。抗生素管理计划(ASP)已证明可改善抗菌药物的使用,减少感染、多重耐药菌的出现以及成本。外科医生在IAI的管理中不应单打独斗,理想情况下应与麻醉医生、内科医生、药剂师和传染病专家一起加入脓毒症治疗团队,定期开会重新评估治疗反应。脓毒症管理的基石是准确诊断、早期复苏、有效的源头控制以及及时开始适当的抗菌治疗。目前的证据表明,优化各外科专业的抗生素使用对于改善预后至关重要。理想情况下,每个医院和每个急诊外科科室都应致力于组建脓毒症治疗团队以管理IAI。